Everstar Asset Management LLC raised its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 58.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,529 shares of the real estate investment trust's stock after purchasing an additional 7,552 shares during the quarter. Everstar Asset Management LLC's holdings in Omega Healthcare Investors were worth $782,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of OHI. NBC Securities Inc. bought a new stake in shares of Omega Healthcare Investors in the 1st quarter worth $29,000. CoreCap Advisors LLC lifted its holdings in Omega Healthcare Investors by 177.3% during the fourth quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock valued at $60,000 after purchasing an additional 1,009 shares during the last quarter. Park Square Financial Group LLC purchased a new stake in shares of Omega Healthcare Investors in the fourth quarter worth about $61,000. UMB Bank n.a. lifted its holdings in shares of Omega Healthcare Investors by 94.9% in the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock worth $83,000 after buying an additional 1,059 shares in the last quarter. Finally, Meeder Asset Management Inc. lifted its holdings in shares of Omega Healthcare Investors by 1,581.3% in the first quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust's stock worth $96,000 after buying an additional 2,372 shares in the last quarter. Institutional investors own 65.25% of the company's stock.
Omega Healthcare Investors Price Performance
NYSE OHI traded down $0.01 during trading hours on Friday, reaching $42.49. The company's stock had a trading volume of 1,550,013 shares, compared to its average volume of 1,686,146. The firm's 50-day moving average price is $40.26 and its 200-day moving average price is $38.23. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $44.42. The company has a market capitalization of $12.53 billion, a price-to-earnings ratio of 26.23, a PEG ratio of 2.23 and a beta of 0.71.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business had revenue of $235.60 million for the quarter, compared to analysts' expectations of $248.49 million. During the same period in the prior year, the firm earned $0.71 EPS. The company's revenue for the quarter was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, equities research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.
Omega Healthcare Investors Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.3%. Omega Healthcare Investors's dividend payout ratio is presently 165.43%.
Insider Buying and Selling at Omega Healthcare Investors
In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares in the company, valued at $749,144.64. This represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 1.50% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on OHI. Raymond James Financial reaffirmed an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Wells Fargo & Company raised their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, August 27th. Royal Bank Of Canada lifted their price target on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a report on Thursday, August 7th. Truist Financial raised their price objective on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research report on Wednesday, September 3rd. Finally, Mizuho lifted their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a research report on Thursday. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Omega Healthcare Investors currently has an average rating of "Moderate Buy" and an average price target of $43.75.
Get Our Latest Analysis on Omega Healthcare Investors
Omega Healthcare Investors Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Read More

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.